Daina Burnes Linton is a prominent inventor based in Marina Del Rey, CA (US). She has made significant contributions to the field of immunology, particularly in the identification and selection of T lymphocytes. With a total of 2 patents, her work is paving the way for advancements in targeted therapies.

Latest Patents

Daina's latest patents focus on innovative methods for identifying desirable T lymphocytes by changes in mass responses. The first patent describes methods for identifying T cell receptors that respond to specific target cell antigens. This involves providing a substrate with a variety of target cells, contacting these cells with CD8+ T cells, and utilizing label-free optical imaging to detect changes in mass. An increase in mass of a T cell or a decrease in mass of a target cell indicates that the T cell receptor is activated by antigens presented on the target cell. The second patent similarly outlines methods for selecting and isolating desirable T lymphocytes based on these mass responses.

Career Highlights

Daina Burnes Linton is affiliated with the University of California, where she continues her research and development in immunology. Her work has garnered attention for its potential applications in therapeutic settings, particularly in cancer treatment and immune response modulation.

Collaborations

Daina collaborates with notable colleagues such as Michael A. Teitell and Thomas A. Zangle. Their combined expertise enhances the research efforts in the field of T cell identification and selection.

Conclusion

Daina Burnes Linton is a trailblazer in T cell research, with her innovative patents contributing to the understanding and application of immunological therapies. Her work exemplifies the intersection of science and technology in advancing healthcare solutions.

Profile summary based on public USPTO records.